Update on the pattern electroretinogram in glaucoma

Optometry and Vision Science

Volumn 85, Issue 6, 2008, Pages 386-395

  Bach, Michael ^a   Hoffmann, Michael B ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Diagnosis; Electrophysiology; Glaucoma; Pattern electroretinogram; PERG

Indexed keywords

DIAGNOSIS; ELECTROPHYSIOLOGY; VISION;

ELECTROPHYSIOLOGICAL TECHNIQUES; GLAUCOMA; PATTERN ELECTRORETINOGRAM; PERG; RETINAL GANGLION CELLS; STIMULATION PARAMETERS; TRANSIENT STIMULATION; VISUAL FIELD DEFECTS;

OPHTHALMOLOGY;

CELL FUNCTION; CLINICAL EFFECTIVENESS; DISEASE COURSE; DISEASE MARKER; EARLY DIAGNOSIS; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; FOURIER ANALYSIS; GLAUCOMA; HUMAN; IMAGE QUALITY; INTRAOCULAR PRESSURE; LONGITUDINAL STUDY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RETINA; RETINA GANGLION CELL; REVIEW; SENSITIVITY ANALYSIS; STEADY STATE; VISUAL FIELD; VISUAL FIELD DEFECT; VISUAL STIMULATION; ELECTRORETINOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; STANDARD; VISION;

DISEASE PROGRESSION; ELECTROPHYSIOLOGY; ELECTRORETINOGRAPHY; GLAUCOMA; HUMANS; LONGITUDINAL STUDIES; PREDICTIVE VALUE OF TESTS; RETINAL GANGLION CELLS; VISION;

EID: 48549102339     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e318177ebf3     Document Type: Review

References (104)

1. Heijl A, Bengtsson B. Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial. Graefes Arch Clin Exp Ophthalmol 2000;238:877-83.
2. Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 2002;120: 1268-79.
3. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK II, Wilson MR, Gordon MO. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120: 701-13.
4. Graham PA. The definition of pre-glaucoma. A prospective study. Trans Ophthalmol Soc UK 1969;88:153-65.
5. Armaly MF. Ocular pressure and visual fields. A ten-year follow-up study. Arch Ophthalmol 1969;81:25-40.
6. Perkins ES. The Bedford glaucoma survey. I. Long-term follow-up of borderline cases. Br J Ophthalmol 1973;57:179-85.
7. Walker WM. Ocular hypertension. Follow-up of 109 cases from 1963 to 1974. Trans Ophthalmol Soc UK 1974;94:525-34.
8. Jensen JE. Glaucoma screening a 16-year follow-up of ocular normotensives. Acta Ophthalmol (Copenh) 1984;62:203-9.
9. Lundberg L, Wettrell K, Linner E. Ocular hypertension. A prospective twenty-year follow-up study. Acta Ophthalmol (Copenh) 1987; 65:705-8.
10. Quigley HA, Kerrigan-Baumrind LA, Pease ME, Kerrigan DF, Mitchell RS. The number of retinal ganglion cells in glaucoma eyes compared to threshold visual field data in the same eyes. Invest Ophthalmol Vis Sci 1999;40:S582.
11. Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci 2000;41:741-8.
12. Quigley HA, Sanchez RM, Dunkelberger GR, L'Hernault NL, Baginski TA. Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci 1987;28:913-20.
13. Lennie P, Trewarthen C, Van Essen D, Wässle H. Parallel processing of visual information. In: Spillmann L, Werner JS, eds. Visual Perception: The Neurophysiological Foundations. San Diego, CA: Academic Press; 1990:103-28.
14. Livingstone MS, Hubel DH. Psychophysical evidence for separate channels for the perception of form, color, movement, and depth. J Neurosci 1987;7:3416-68.
15. Livingstone M, Hubel D. Segregation of form, color, movement, and depth: anatomy, physiology, and perception. Science 1988;240: 740-9.
16. Skottun BC, Skoyles JR. Some remarks on the use of visually evoked potentials to measure magnocellular activity. Clin Neurophysiol 2007;118:1903-5.
17. Johnson CA, Spry PGD, Cioffi GA, Mansberger SL. Evaluation of a variety of visual function tests in ocular hypertension and early glaucoma patients. Invest Ophthalmol Vis Sci 2000;41:S104.
18. Crawford ML, Harwerth RS, Smith EL 3rd, Shen F, Carter-Dawson L. Glaucoma in primates: cytochrome oxidase reactivity in parvo- and magnocellular pathways. Invest Ophthalmol Vis Sci 2000;41:1791-802.
19. Yücel YH, ZhangQ, Weinreb RN, Kaufman PL, GuptaN.Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma. Invest Ophthalmol Vis Sci 2001;42:3216-22.
20. Yücel YH, Zhang Q, Weinreb RN, Kaufman PL, Gupta N. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res 2003;22:465-81.
21. Sample PA. Short-wavelength automated perimetry: it's role in the clinic and for understanding ganglion cell function. Prog Retin Eye Res 2000;19:369-83.
22. Hood DC, Greenstein VC. Multifocal VEP and ganglion cell damage: applications and limitations for the study of glaucoma. Prog Retin Eye Res 2003;22:201-51.
23. Viswanathan S, Frishman LJ, Robson JG. The uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity. Invest Ophthalmol Vis Sci 2000;41:2797-810.
24. Viswanathan S, Frishman LJ, Robson JG, Walters JW. The photopic negative response of the flash electroretinogram in primary open angle glaucoma. Invest Ophthalmol Vis Sci 2001;42:514-22.
25. Korth MJ, Junemann AM, Horn FK, Bergua A, Cursiefen C, Velten I, Budde WM, Wisse M, Martus P. [Synopsis of various electrophysiological tests in early glaucoma diagnosis-temporal and spatiotemporal contrast sensitivity, light- and color-contrast pattern-reversal electroretinogram, blue-yellow VEP.] Klin Monatsbl Augenheilkd 2000;216:360-8.
26. Gouras P. The role of S-cones in human vision. Doc Ophthalmol 2003;106:5-11.
27. Johnson CA, Adams AJ, Casson EJ, Brandt JD. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol 1993;111:645-50.
28. Horn FK, Jonas JB, Budde WM, Junemann AM, Mardin CY, Korth M. Monitoring glaucoma progression with visual evoked po- tentials of the blue-sensitive pathway. Invest Ophthalmol Vis Sci 2002;43:1828-34.
29. Aldebasi YH, Drasdo N, Morgan JE, North RV. S-cone, L + M-cone, and pattern, electroretinograms in ocular hypertension and glaucoma. Vision Res 2004;44:2749-56.
30. Goldberg I, Graham SL, Klistorner AI. Multifocal objective perimetry in the detection of glaucomatous field loss. Am J Ophthalmol 2002;133:29-39.
31. Hood DC, Thienprasiddhi P, Greenstein VC, Winn BJ, Ohri N, Liebmann JM, Ritch R. Detecting early to mild glaucomatous damage: a comparison of the multifocal VEP and automated perimetry. Invest Ophthalmol Vis Sci 2004;45:492-8.
32. Hood DC. Objective measurement of visual function in glaucoma. Curr Opin Ophthalmol 2003;14:78-82.
33. Fortune B, Demirel S, Zhang X, Hood DC, Patterson E, Jamil A, Mansberger SL, Cioffi GA, Johnson CA. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma. Invest Ophthalmol Vis Sci 2007;48: 1173-80.
34. Johnson MA, Drum BA, Quigley HA, Sanchez RM, Dunkelberger GR. Pattern-evoked potentials and optic nerve fiber loss in monocular laser-induced glaucoma. Invest Ophthalmol Vis Sci 1989;30: 897-907.
35. Heinrich TS, Bach M. Contrast adaptation in human retina and cortex. Invest Ophthalmol Vis Sci 2001;42:2721-7.
36. Heinrich TS, Bach M. Contrast adaptation in retinal and cortical evoked potentials: no adaptation to low spatial frequencies. Vis Neurosci 2002;19:645-50.
37. Solomon SG, Peirce JW, Dhruv NT, Lennie P. Profound contrast adaptation early in the visual pathway. Neuron 2004;42:155-62.
38. Holder GE. Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res 2001;20: 531-61.
39. Bach M, Hoffmann MB. The origin of the pattern electroretinogram (PERG). In: Heckenlively JR, Arden GB, eds. Principles and Practice of Clinical Electrophysiology of Vision. Cambridge, MA: MIT Press; 2006:185-96.
40. Holder GE, Brigell MG, Hawlina M, Meigen T, Vaegan, Bach M. ISCEV standard for clinical pattern electroretinography-2007 update. Doc Ophthalmol 2007;114:111-16.
41. Bach M, Gerling J, Geiger K. Optic atrophy reduces the patternelectroretinogram for both fine and coarse stimulus patterns. Clin Vision Sci 1992;7:327-33.
42. Sieving PA, Steinberg RH. Proximal retinal contributions to the intraretinal 8-Hz pattern ERG of cat. J Neurophysiol 1987;57: 104-20.
43. Zrenner E. The physiological basis of the pattern electroretinogram. Prog Retinal Res 1989;9:427-64.
44. Groneberg A, Teping C. Topodiagnostik von Sehstörungen durch Ableitung retinaler und kortikaler Antworten auf Umkehr-Kontrastmuster. Ber Zusammenkunft Dtsch Ophthalmol Ges 1980;77:409-15.
45. Mafei L, Fiorentini A. Electroretinographic responses to alternating gratings before and after section of the optic nerve. Science 1981; 211:953-5.
46. Dawson WW, Trick GL, Litzkow CA. Improved electrode for electroretinography. Invest Ophthalmol Vis Sci 1979;18:988-91.
47. Bach M. Preparation and Montage of DTL-Electrodes. Available at: http://www.michaelbach.de/dtl.html. Accessed September 25, 2007.
48. Hawlina M, Konec B. New noncorneal HK-loop electrode for clinical electroretinography. Doc Ophthalmol 1992;81:253-9.
49. Hess RF, Baker CL Jr. Human pattern-evoked electroretinogram. J Neurophysiol 1984;51:939-51.
50. Thompson D, Drasdo N. The effect of stimulus contrast on the latency and amplitude of the pattern electroretinogram. Vision Res 1989;29:309-13.
51. Zapf HR, Bach M. The contrast characteristic of the pattern electroretinogram depends on temporal frequency. Graefes Arch Clin Exp Ophthalmol 1999;237:93-9.
52. Otto T, Bach M. Retest variability and diurnal effects in the pattern electroretinogram. Doc Ophthalmol 1996;92:311-23.
53. May JG, Ralston JV, Reed JL, Van Dyk HJ. Loss in pattern-elicited electroretinograms in optic nerve dysfunction. Am J Ophthalmol 1982;93:418-22.
54. Bobak P, Bodis-Wollner I, Harnois C, Maffei L, Mylin L, Podos S, Thornton J. Pattern electroretinograms and visual-evoked potentials in glaucoma and multiple sclerosis. Am J Ophthalmol 1983;96: 72-83.
55. Wanger P, Persson HE. Pattern-reversal electroretinograms in unilateral glaucoma. Invest Ophthalmol Vis Sci 1983;24:749-53.
56. Wanger P, Persson HE. Pattern-reversal electroretinograms in ocular hypertension. Doc Ophthalmol 1985;61:27-31.
57. Papst N, Bopp M, Schnaudigel OE. The pattern evoked electroretinogram associated with elevated intraocular pressure. Graefes Arch Clin Exp Ophthalmol 1984;222:34-7.
58. Porciatti V, Falsini B, Brunori S, Colotto A, Moretti G. Pattern electroretinogram as a function of spatial frequency in ocular hypertension and early glaucoma. Doc Ophthalmol 1987;65:349-55.
59. Bach M, Hiss P, Rover J. Check-size specific changes of pattern electroretinogram in patients with early open-angle glaucoma. Doc Ophthalmol 1988;69:315-22.
60. Price MJ, Drance SM, Price M, Schulzer M, Douglas GR, Tansley B. The pattern electroretinogram and visual-evoked potential in glaucoma. Graefes Arch Clin Exp Ophthalmol 1988;226:542-7.
61. Trick GL, Bickler-Bluth M, Cooper DG, Kolker AE, Nesher R. Pattern reversal electroretinogram (PRERG) abnormalities in ocular hypertension: correlation with glaucoma risk factors. Curr Eye Res 1988;7:201-6.
62. Weinstein GW, Arden GB, Hitchings RA, Ryan S, Calthorpe CM, Odom JV. The pattern electroretinogram (PERG) in ocular hypertension and glaucoma. Arch Ophthalmol 1988;106:923-8.
63. Bach M, Speidel-Fiaux A. Pattern electroretinogram in glaucoma and ocular hypertension. Doc Ophthalmol 1989;73:173-81.
64. Korth M, Horn F, Storck B, Jonas J. The pattern-evoked electro-retinogram (PERG): age-related alterations and changes in glaucoma. Graefes Arch Clin Exp Ophthalmol 1989;227:123-30.
65. Garway-Heath DF, Holder GE, Fitzke FW, Hitchings RA. Relationship between electrophysiological, psychophysical, and anatomical measurements in glaucoma. Invest Ophthalmol Vis Sci 2002; 43:2213-20.
66. Parisi V, Manni G, Centofanti M, Gandolfi SA, Olzi D, Bucci MG. Correlation between optical coherence tomography, pattern electroretinogram, and visual evoked potentials in open-angle glaucoma patients. Ophthalmology 2001;108:905-12.
67. Bach M. Electrophysiological approaches for early detection of glaucoma. Eur J Ophthalmol 2001;11(suppl 2):S41-S49.
68. Pfeiffer N, Tillmon B, Bach M. Predictive value of the pattern electroretinogram in high-risk ocular hypertension. Invest Ophthalmol Vis Sci 1993;34:1710-15.
69. Maddess T, James AC, Goldberg I, Wine S, Dobinson J. Comparing a parallel PERG, automated perimetry, and frequency-doubling thresholds. Invest Ophthalmol Vis Sci 2000;41:3827-32.
70. Bayer AU, Maag KP, Erb C. Detection of optic neuropathy in glaucomatous eyes with normal standard visual fields using a test battery of short-wavelength automated perimetry and pattern electroretinography. Ophthalmology 2002;109:1350-61.
71. Unsoeld AS, Walter S, Meyer J, Funk J, Bach M. Pattern ERG as early risk indicator in ocular hypertension-an 8-year prospective study. Invest Ophthalmol Vis Sci 2001;42:S146.
72. Philippin H, Unsoeld AS, Maier P, Staubach F, Walter HS, Funk J, Bach M. Pattern ERG as early risk indicator in ocular hypertension-a long-term follow-up study. Invest Ophthalmol Vis Sci 2005;46:E-Abstract 3757.
73. Ventura LM, Porciatti V, Ishida K, Feuer WJ, Parrish RK II. Pattern electroretinogram abnormality and glaucoma. Ophthalmology 2005;112:10-19.
74. van den Berg TJ, Riemslag FC, de Vos GW, Verduyn Lunel HF. Pattern ERG and glaucomatous visual field defects. Doc Ophthalmol 1986;61:335-41.
75. Bach M, Hawlina M, Holder GE, Marmor MF, Meigen T, Vaegan, Miyake Y. Standard for pattern electroretinography. International society for clinical electrophysiology of vision. Doc Ophthalmol 2000;101:11-18.
76. Hood DC, Xu L, Thienprasiddhi P, Greenstein VC, Odel JG, Grippo TM, Liebmann JM, Ritch R. The pattern electroretinogram in glaucoma patients with confirmed visual field deficits. Invest Ophthalmol Vis Sci 2005;46:2411-18.
77. Hiss P, Fahl G. [Changes in the pattern electroretinogram in glaucoma and ocular hypertension are dependent on stimulus frequency.] Fortschr Ophthalmol 1991;88:562-5.
78. Trick GL. Retinal potentials in patients with primary open-angle glaucoma: physiological evidence for temporal frequency tuning deficits. Invest Ophthalmol Vis Sci 1985;26:1750-8.
79. Tyler CW. Specific deficits of flicker sensitivity in glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 1981;20:204-12.
80. Horn FK, Velten IM, Junemann A, Korth M. The full-field flicker test in glaucomas: influence of intraocular pressure and pattern of visual field losses. Graefes Arch Clin Exp Ophthalmol 1999;237: 621-8.
81. Holder GE. Recording the pattern electroretinogram with the Arden gold foil electrode. J Electrophysiol Technol 1988;14: 183-90.
82. Zrenner E, Ziegler R, Voss B. Clinical applications of pattern electroretinography: melanoma, retinal detachment and glaucoma. Doc Ophthalmol 1988;68:283-92.
83. Bach M, Meigen T, Strasburger H. Raster-scan cathode-ray tubes for vision research-limits of resolution in space, time and intensity, and some solutions. Spat Vis 1997;10:403-14.
84. Bach M, Pfeiffer N, Birkner-Binder D. Pattern-electroretinogram reflects diffuse retinal damage in early glaucoma. Clin Vision Sci 1992;7:335-40.
85. Porciatti V, Ventura LM. Normative data for a user-friendly paradigm for pattern electroretinogram recording. Ophthalmology 2004;111:161-8.
86. Ventura LM, Porciatti V. Pattern electroretinogram in glaucoma. Curr Opin Ophthalmol 2006;17:196-202.
87. Yang A, Swanson WH. A new pattern electroretinogram paradigm evaluated in terms of user friendliness and agreement with perimetry. Ophthalmology 2007;114:671-9.
88. Ventura LM, Porciatti V. Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study. Ophthalmology 2005;112:20-7.
89. van den Berg TJ, Boltjes B. The point-spread function of the eye from 0 degrees to 100 degrees and the pattern electroretinogram. Doc Ophthalmol 1987;67:347-54.
90. Leipert KP, Gottlob I. Pattern electroretinogram: effects of miosis, accommodation, and defocus. Doc Ophthalmol 1987;67:335-46.
91. Ver Hoeve JN, Danilov YP, Kim CB, Spear PD. VEP and PERG acuity in anesthetized young adult rhesus monkeys. Vis Neurosci 1999;16:607-17.
92. Bach M, Mathieu M. Different effect of dioptric defocus vs. light scatter on the pattern electroretinogram (PERG). Doc Ophthalmol 2004;108:99-106.
93. Smith G. Ocular defocus, spurious resolution and contrast reversal. Ophthalmic Physiol Opt 1982;2:5-23.
94. Drasdo N, Aldebasi YH, Mortlock KE, Chiti Z, Morgan JE, North RV, Wild JM. Ocular optics, electroretinography and primary open angle glaucoma. Ophthalmic Physiol Opt 2002;22:455-62.
95. Bach M. The Freiburg visual acuity test - automatic measurement of visual acuity. Optom Vis Sci 1996;73:49-53.
96. Bach M, Unsoeld AS, Philippin H, Staubach F, Maier P, Walter HS, Bomer TG, Funk J. Pattern ERG as an early glaucoma indicator in ocular hypertension: a long-term, prospective study. Invest Ophthalmol Vis Sci 2006;47:4881-7.
97. Hoffmann MB, Flechner JJ. Slow pattern-reversal stimulation facilitates the assessment of retinal function with multifocal recordings. Clin Neurophysiol 2008;119:409-17.
98. Klistorner A, Graham SL. Objective perimetry in glaucoma. Ophthalmology 2000;107:2283-99.
99. Lindenberg T, Horn FK, Korth M. [Multifocal steady-state patternreversal electroretinography in glaucoma patients.] Ophthalmologe 2003;100:453-8.
100. Stiefelmeyer S, Neubauer AS, Berninger T, Arden GB, Rudolph G. The multifocal pattern electroretinogram in glaucoma. Vision Res 2004;44:103-12.
101. Harrison WW, Viswanathan S, Malinovsky VE. Multifocal pattern electroretinogram: cellular origins and clinical implications. Optom Vis Sci 2006;83:473-85.
102. Pekny M, Johansson CB, Eliasson C, Stakeberg J, Wallen A, Perlmann T, Lendahl U, Betsholtz C, Berthold CH, Frisen J. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 1999;145:503-14.
103. Pekny M, Wilhelmsson U, Bogestal YR, Pekna M. The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 2007;82:95-111.
104. Bach M, Sulimma F, Gerling J. Little correlation of the pattern electroretinogram (PERG) and visual field measures in early glaucoma. Doc Ophthalmol 1997;94:253-63.